Clinical Trial Update: A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating Ginsenoside H Dripping Pills for advanced non-small cell lung cancer, sponsored by Tasly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ginsenoside H Dripping Pills (Ginsenoside H)

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 2 | Status: UNKNOWN